The Cancer Drug Development Forum (CDDF) is delighted to announced that the executive summary of this year’s Annual Conference has been published today and is available to all our stakeholders.
This multi-stakeholder conference took place on 9-11 February 2026 in Ghent (BE), bringing together the community of oncology drug development. The meeting focused on the rapidly evolving global environment of cancer clinical research. The discussion covered key topics such as global clinical development, representativeness in global clinical trials, patient relevant endpoints, the use of big data in oncology drug development, and diversity in clinical trials.
To learn more about our discussions, read the executive summary and feel free to share your thoughts with us.